Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of

Jumpei Teramachi1, Hua Zhou, Mark A Subler

  • 1Department of Medicine, Hematology Oncology, Indiana University, Indianapolis, IN.

Insights

Measles virus nucleocapsid protein (MVNP) and mutant SQSTM1 (p62) gene mutations increase osteoclast (OCL) activity in Paget's disease (PD). Elevated interleukin-6 (IL-6) contributes to PD but is insufficient alone to cause pagetic lesions.

Area of Science:

  • Bone biology and disease
  • Cellular and molecular pathology
  • Genetics and epigenetics

Background:

  • Paget's disease of bone (PD) is characterized by increased osteoclast (OCL) activity.
  • Measles virus nucleocapsid protein (MVNP) expression and SQSTM1 (p62) gene mutations are implicated in PD pathogenesis.
  • Interleukin-6 (IL-6) is essential for the pagetic phenotype, but the precise role of IL-6 in conjunction with p62 mutations requires further elucidation.

Purpose of the Study:

  • To investigate the role of elevated IL-6 in PD.
  • To determine if MVNP mediates its effects on PD primarily through IL-6 elevation.
  • To assess whether IL-6 overexpression cooperates with mutant p62 to induce pagetic lesions.

Main Methods:

  • Generation of transgenic mice overexpressing IL-6 under the tartrate-resistant acid phosphatase (TRAP) promoter (TIL-6 mice).
  • Crossbreeding TIL-6 mice with p62(P394L) knock-in mice (p62KI) to create p62KI/TIL-6 mice.
  • Analysis of OCL precursor differentiation, bone histomorphometry, and micro-quantitative CT (µQCT) in generated mouse models.

Main Results:

  • OCL precursors from p62KI/TIL-6 mice showed increased responsiveness to 1,25-dihydroxyvitamin D3 (1,25-(OH)2 D3) and formed greater numbers of OCLs compared to controls.
  • Histomorphometric analysis revealed increased OCL numbers per bone surface area in p62KI/TIL-6 mice versus wild-type (WT) mice.
  • Micro-quantitative CT (µQCT) analysis did not reveal significant differences between p62KI/TIL-6 and WT mice, and no pagetic OCLs or lesions were detected in vivo.

Conclusions:

  • Increased IL-6 expression in OCLs contributes to enhanced 1,25-(OH)2 D3 responsiveness and increased OCL numbers in the context of mutant p62.
  • Elevated IL-6 alone, even in the presence of mutant p62, is not sufficient to induce Paget's-like osteoclasts or bone lesions in vivo.
  • These findings highlight the complex interplay of genetic and viral factors in PD pathogenesis, with IL-6 playing a contributory but not solely causative role.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K